Can AbCellera Biologics' Vertex Pharmaceuticals Deal Turn Its TCE Platform into a Breakthrough? In the high stakes world of pharmaceutical research and development, partnerships are crucial for driving innovation.
Companies like Vertex Pharmaceuticals and AbCellera Biologics have collaborated on various projects in the past, but when it comes to revolutionary treatments, progress can be slow.
A recent $28 million deal between AbCellera and Vertex has sparked industry interest: will this partnership propel AbCellera's TCE platform into mainstream success?